Aptorum Group Limited (APM) - Bathi pungkasan

Simbol resmi perusahaan Aptorum Group Limited (APM)

Aptorum Group Limited (APM) is seeing its generated profits soar amid an influx of liquidity, with the metric holding around -0.00. Aptorum Group Limited (APM) attracts biochemists through its interdisciplinary approach and stability. The organization brings together experts for the therapy of orphan pathologies, granting scientists broad autonomy. The business is currently fighting for the attention of major buyers while developing its drug portfolio under constrained resources.

Penghasilan resik: aptorumgroup.com (APM) kanggo 04.07.2022 - 20.07.2026

Rincian metrik keuangan lan pasar aptorumgroup.com (APM)

- nilai pasar lan prakiraan target analis:
Rega saham Aptorum Group|APM - Target konsensus
- indikator kapitalisasi pasar:
Nilai pasar APM|APM - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Aset Bersih saben Saham Aptorum Group|APM - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku aptorumgroup.com|APM - Total Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Aptorum Group Limited|APM - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Aptorum Group|APM - Utang perusahaan|Rasio utang marang aset resik APM|APM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Aptorum Group|Rasio likuiditas kritis aptorumgroup.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
APM - Penghasilan resik
Analisis dhasar perusahaan:Aptorum (APM)
Produk sing diprodhuksi Aptorum Group Limited

To minimize risks amid uncertainty, it is crucial for investors to track a business's actual ability to generate cash flow, excluding accounting adjustments. Analyzing the net income trends of Aptorum Group Limited (APM) can reveal the depletion of reserves, which is critical for Aptorum Group Limited (APM) during its R&D portfolio restructuring and search for strategic partners while clinical releases are temporarily deferred.

Pesaing langsung

Haleon Corp (HLN) - Bathi resik|Penghasilan resik KVUE|VRNA: Bathi pungkasan|Bathi resik perusahaan Jyong Biotech (MENS)|LGND - Penghasilan resik perusahaan|Amneal Pharmaceuticals Inc - Penghasilan resik|Bathi sawise mbayar pajeg PRGO (Perrigo Corp)|Alvotech - Bathi resik|Bathi pungkasan LQDA (liquidia.com)|GLPG: Bathi resik|Penghasilan resik perusahaan ANI Pharmaceuticals Inc (ANIP)|Bathi resik perusahaan MannKind Corp.|AMPH: Bathi pungkasan|Bathi resik PCRX|Bathi resik ars-pharma.com (SPRY)|Bathi resik perusahaan Theravance Biopharma, Inc. TBPH|AQST (Aquestive Therapeutics Inc) - Bathi sawise pajeg|SCPH: Penghasilan resik|Tectonic Therapeutic, Inc. - Bathi sawise mbayar pajeg|Tonix Pharmaceuticals (TNXP) - Bathi resik perusahaan|Penghasilan resik perusahaan China SXT Pharmaceuticals, Inc. (SXTC)|Bathi resik perusahaan Eupraxia Pharmaceuticals, Inc.|BHST: Bathi pungkasan|Penghasilan resik EXOZ (Invizyne Technologies, Inc.)|Bathi resik oramed.com (ORMP)|Bathi resik perusahaan Entera Bio ENTX|HYFT - Penghasilan resik|ABVC: Penghasilan resik|Bathi pungkasan CPIX (Cumberland Pharmaceuticals Inc)|QNTM: Bathi resik|Bathi resik taunan FibroGen Corporation FGEN|Bathi resik perusahaan Telomir Pharmaceuticals|RANI: Bathi pungkasan|Bathi resik perusahaan Synergy CHC Corp (SNYR)|RLYB - Penghasilan resik perusahaan|Lexaria Bioscience Corp. - Penghasilan resik|Bathi resik Pulmatrix Corporation PULM|PTHL - Bathi resik perusahaan|Bathi sawise pajeg LYRA|IBO (Impact BioMedical Inc) - Penghasilan resik|TNF Pharmaceuticals, Inc. - Bathi pungkasan|Bathi resik perusahaan cbdMD Inc.|Bathi resik perusahaan PRFX|Bathi resik CYTO|Asil keuangan resik lipella.com|Bathi resik perusahaan OptiNose OPTN|PIRS - Penghasilan resik|Procaps Group SA - Bathi resik|Asil keuangan resik Petros Pharma PTPI|QLI (Qilian International) - Penghasilan resik|SLRN: Bathi sawise mbayar pajeg|TFFP (TFF Pharmaceuticals, Inc.) - Bathi resik